Monitoring NPHI development: a collaborative tool

Paris Consultancy

February 16, 2015

Christina Craig

Hosted by France's InVS and facilitated by the U.S. CDC, a working group convened in Paris, France, last week for a high level discussion on the development of an NPHI Staged Development Tool, including the tool's purpose, structure, and practical application. The nature of the tool's development process reflects the peer-to-peer collaboration that is paramount to IANPHI's work, and members of the working group noted the high value of meeting with leaders of other NPHIs across IANPHI's global network.

Having met previously in October 2014, the workshop in France was the second meeting of a working group of representatives from more than ten IANPHI member institutes. Led by the U.S. CDC, the group aims to develop and refine a dynamic tool that can be applied to diverse NPHI contexts to monitor the progress and development of an NPHI, namely in its ability to address specific public health functions. The tool’s key elements are based on existing models of public health functions and operations as defined by the WHOPAHO, the U.S. CDC, and others.

The group will meet again later this year to discuss pilot testing of the development tool. 


2015 NPHI Development Tool Consultancy Group:

Dr. Ezra Barzilay, Shelly Bratton, Henry Vandi, Dr. Craig Thomas, U.S. CDC

Dr. Reinhard Burger, Germany Robert Koch Institute

Dr. Placido Cardoso, Guinea Bissau National Institute of Public Health

Courtenay Dusenbury, IANPHI U.S. Office

Dr. Mohamed Guled Farah, Somalia National Institute of Health

Dr. Frode Forland, Norwegian Institute of Public Health

Dr. Mohamed Rhajaoui, Morocco National Institute of Hygiene

Dr. Felix Rosenberg, FIOCRUZ Brazil

Dr. Mark Salter, Public Health England

Dr. Anne Catherine Viso, Dr. Jean Claude Desenclos, Dr. Bertrand Xerri, Dorianne Fuchs, National Institute of Health Surveillance, France


Related Links: 

IANPHI NPHI Evaluation Initiative

IANPHI Evaluation Tool